دورية أكاديمية
Spectrum of anti-NMDA receptor antibody encephalitis: Clinical profile, management and outcomes
العنوان: | Spectrum of anti-NMDA receptor antibody encephalitis: Clinical profile, management and outcomes |
---|---|
المؤلفون: | Amlan Kusum Datta, Alak Pandit, Samar Biswas, Atanu Biswas, Biman Kanti Roy, Goutam Gangopaddhyay |
المصدر: | Annals of Indian Academy of Neurology, Vol 24, Iss 3, Pp 383-389 (2021) |
بيانات النشر: | Wolters Kluwer Medknow Publications, 2021. |
سنة النشر: | 2021 |
المجموعة: | LCC:Neurology. Diseases of the nervous system |
مصطلحات موضوعية: | anti nmdar, autoimmune, encephalitis, immunotherapy, Neurology. Diseases of the nervous system, RC346-429 |
الوصف: | Background: Anti-N-methyl D-aspartate receptor (anti NMDAR) antibody encephalitis is an immune-mediated entity characterised by a constellation of neuro-psychiatric symptoms. Objective: To describe clinical profile and treatment outcomes of patients with anti NMDAR antibody encephalitis. Settings and Design: Subjects were selected by screening for all patients satisfying Graus et al.'s criteria for probable anti NMDAR antibody encephalitis, admitted in neurology department of a tertiary care centre in Eastern India. Materials and Methods: A prospective, longitudinal study was conducted by identifying 25 patients with anti NMDAR antibodies in CSF and or serum, between September 2018 to February 2020. Statistical Analysis: Chi square test was used to compare variables. Results: Out of 98 patients screened, 25 subjects (14 females: 11 male) were positive for anti NMDAR autoantibodies, with a mean age of 17 years. 13 subjects belonged to paediatric age group. Most common presenting feature was memory/learning deficit (88%) followed by behavioural abnormalities (84%) and seizures (68%). 11 patients (44%) patients needed escalation to second line therapy, rituximab. Seven (28%) and twelve (48%) patients underwent complete (mRS 0-1) and partial recovery (mRS 2-3) respectively, while 4 (16%) became disabled (mRS 4-5). Mortality was 8%. Paediatric population had a better outcome in terms of disability (p = 0.043). Conclusion: Anti NMDAR-Ab encephalitis is the most common cause of antibody positive autoimmune encephalitis worldwide. There are important clinical markers and investigational profiles which carry prognostic significance. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 0972-2327 1998-3549 |
Relation: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2021;volume=24;issue=3;spage=383;epage=389;aulast=Datta; https://doaj.org/toc/0972-2327; https://doaj.org/toc/1998-3549 |
DOI: | 10.4103/aian.AIAN_817_20 |
URL الوصول: | https://doaj.org/article/0bea84d7e0b84eee8d00d6ecfbc0c247 |
رقم الأكسشن: | edsdoj.0bea84d7e0b84eee8d00d6ecfbc0c247 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 09722327 19983549 |
---|---|
DOI: | 10.4103/aian.AIAN_817_20 |